These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 10633468

  • 21. Strontium causes osteomalacia in chronic renal failure rats.
    Schrooten I, Cabrera W, Goodman WG, Dauwe S, Lamberts LV, Marynissen R, Dorriné W, De Broe ME, D'Haese PC.
    Kidney Int; 1998 Aug; 54(2):448-56. PubMed ID: 9690211
    [Abstract] [Full Text] [Related]

  • 22. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V, Torregrosa V.
    Nefrologia; 2008 Aug; 28 Suppl 3():67-78. PubMed ID: 19018742
    [Abstract] [Full Text] [Related]

  • 23. Prevention of metabolic bone disease in the pre-end-stage renal disease setting.
    Coburn JW, Elangovan L.
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S71-7. PubMed ID: 11443772
    [Abstract] [Full Text] [Related]

  • 24. Aluminum deposition at the osteoid-bone interface. An epiphenomenon of the osteomalacic state in vitamin D-deficient dogs.
    Quarles LD, Dennis VW, Gitelman HJ, Harrelson JM, Drezner MK.
    J Clin Invest; 1985 May; 75(5):1441-7. PubMed ID: 3998143
    [Abstract] [Full Text] [Related]

  • 25. [Renal osteodystrophy (2): its treatment in renal insufficiency before dialysis].
    Hottelart C, Bako G, Oprisiu R, Georgita A, Presne C, Sarraj A, Morinière P, el Esper N, Fournier A.
    Nephrologie; 2000 May; 21(6):275-82. PubMed ID: 11117106
    [Abstract] [Full Text] [Related]

  • 26. Recent advances in pediatric metabolic bone disease: the consequences of altered phosphate homeostasis in renal insufficiency and hypophosphatemic vitamin D-resistant rickets.
    Pettifor JM.
    Bone Miner; 1990 Jun; 9(3):199-214. PubMed ID: 2163713
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The pathogenesis of osteodystrophy after renal transplantation as detected by early alterations in bone remodeling.
    Rojas E, Carlini RG, Clesca P, Arminio A, Suniaga O, De Elguezabal K, Weisinger JR, Hruska KA, Bellorin-Font E.
    Kidney Int; 2003 May; 63(5):1915-23. PubMed ID: 12675872
    [Abstract] [Full Text] [Related]

  • 29. Changing bone patterns with progression of chronic kidney disease.
    Drüeke TB, Massy ZA.
    Kidney Int; 2016 Feb; 89(2):289-302. PubMed ID: 26806832
    [Abstract] [Full Text] [Related]

  • 30. 1-alpha-Hydroxyvitamin D3 derivatives in the treatment of renal bone diseases: justification and optimal modalities of administration.
    Fournier A, Morinière PH, Oprisiu R, Yverneau-Hardy P, Westeel PF, Mazouz H, el Esper N, Ghazali A, Boudailliez B.
    Nephron; 1995 Feb; 71(3):254-83. PubMed ID: 8569975
    [Abstract] [Full Text] [Related]

  • 31. [Pathological analysis of renal osteodystrophy in 194 cases].
    Yu YF.
    Zhonghua Bing Li Xue Za Zhi; 1991 Dec; 20(4):280-3. PubMed ID: 1813163
    [Abstract] [Full Text] [Related]

  • 32. 22-oxacalcitriol suppresses secondary hyperparathyroidism without inducing low bone turnover in dogs with renal failure.
    Monier-Faugere MC, Geng Z, Friedler RM, Qi Q, Kubodera N, Slatopolsky E, Malluche HH.
    Kidney Int; 1999 Mar; 55(3):821-32. PubMed ID: 10027919
    [Abstract] [Full Text] [Related]

  • 33. [Secondary hyperparathyroidism and tertiary hyperparathyroidism chronic renal failure, uremia].
    Morio K, Koide K.
    Nihon Rinsho; 1995 Apr; 53(4):958-64. PubMed ID: 7752492
    [Abstract] [Full Text] [Related]

  • 34. Mixed uremic osteodystrophy: an ill-described common bone pathology in patients with chronic kidney disease.
    Elkhouli E, Nagy E, Santos CGS, Barreto FC, Chaer J, Jorgetti V, El-Husseini A.
    Osteoporos Int; 2023 Dec; 34(12):2003-2012. PubMed ID: 37658999
    [Abstract] [Full Text] [Related]

  • 35. [Ultrasonography methods in the diagnosis of renal osteodystrophy].
    Tomić-Brzac H, Pavlović D.
    Acta Med Croatica; 2004 Dec; 58(1):43-9. PubMed ID: 15125393
    [Abstract] [Full Text] [Related]

  • 36. The effect of 1alpha(OH)D3 and 1alpha,25(OH)2D3 on the bone in patients with renal osteodystrophy.
    Bordier P, Zingraff J, Gueris J, Jungers P, Marie P, Pechet M, Rasmussen H.
    Am J Med; 1978 Jan; 64(1):101-7. PubMed ID: 623125
    [Abstract] [Full Text] [Related]

  • 37. Useful biochemical markers for diagnosing renal osteodystrophy in predialysis end-stage renal failure patients.
    Bervoets AR, Spasovski GB, Behets GJ, Dams G, Polenakovic MH, Zafirovska K, Van Hoof VO, De Broe ME, D'Haese PC.
    Am J Kidney Dis; 2003 May; 41(5):997-1007. PubMed ID: 12722034
    [Abstract] [Full Text] [Related]

  • 38. Relative hypoparathyroidism and adynamic bone disease.
    Mucsi I, Hercz G.
    Am J Med Sci; 1999 Jun; 317(6):405-9. PubMed ID: 10372841
    [Abstract] [Full Text] [Related]

  • 39. Prevention of renal osteodystrophy in peritoneal dialysis.
    Weinreich T.
    Kidney Int; 1998 Dec; 54(6):2226-33. PubMed ID: 9853289
    [Abstract] [Full Text] [Related]

  • 40. Pathogenesis of osteomalacia in chronic renal failure and its relationship to vitamin D.
    Kanis JA, Hamdy NA, Cundy T.
    Ann Med Interne (Paris); 1986 Dec; 137(3):193-9. PubMed ID: 3532899
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.